SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-002081
Filing Date
2020-03-05
Accepted
2020-03-05 17:13:04
Documents
89
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K knsa-20191231x10k.htm 10-K 3381009
2 EX-4.3 knsa-20191231ex432cb0dd4.htm EX-4.3 50556
3 EX-10.24 knsa-20191231ex1024a4271.htm EX-10.24 70911
4 EX-10.25 knsa-20191231ex102510fda.htm EX-10.25 100105
5 EX-23.1 knsa-20191231ex231176b06.htm EX-23.1 2818
6 EX-31.1 knsa-20191231ex311b0ab26.htm EX-31.1 16222
7 EX-31.2 knsa-20191231ex312dbcb90.htm EX-31.2 16157
8 EX-32.1 knsa-20191231ex321d2daa2.htm EX-32.1 8125
9 EX-32.2 knsa-20191231ex3222b0d12.htm EX-32.2 8001
10 GRAPHIC knsa20191231ex1024a4271001.jpg GRAPHIC 9304
11 GRAPHIC knsa20191231x10k001.jpg GRAPHIC 73040
12 GRAPHIC knsa20191231x10k002.jpg GRAPHIC 197973
13 GRAPHIC knsa20191231x10k003.jpg GRAPHIC 92412
  Complete submission text file 0001558370-20-002081.txt   11034598

Data Files

Seq Description Document Type Size
14 EX-101.INS knsa-20191231.xml EX-101.INS 1773845
15 EX-101.SCH knsa-20191231.xsd EX-101.SCH 80935
16 EX-101.CAL knsa-20191231_cal.xml EX-101.CAL 62086
17 EX-101.DEF knsa-20191231_def.xml EX-101.DEF 374762
18 EX-101.LAB knsa-20191231_lab.xml EX-101.LAB 679587
19 EX-101.PRE knsa-20191231_pre.xml EX-101.PRE 556697
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38492 | Film No.: 20691667
SIC: 2834 Pharmaceutical Preparations